74 related articles for article (PubMed ID: 22733450)
1. Design of human granzyme B variants resistant to serpin B9.
Losasso V; Schiffer S; Barth S; Carloni P
Proteins; 2012 Nov; 80(11):2514-22. PubMed ID: 22733450
[TBL] [Abstract][Full Text] [Related]
2. Predicting serpin/protease interactions.
Song J; Matthews AY; Reboul CF; Kaiserman D; Pike RN; Bird PI; Whisstock JC
Methods Enzymol; 2011; 501():237-73. PubMed ID: 22078538
[TBL] [Abstract][Full Text] [Related]
3. Design and characterization of a novel human Granzyme B inhibitor.
Marcet-Palacios M; Ewen C; Pittman E; Duggan B; Carmine-Simmen K; Fahlman RP; Bleackley RC
Protein Eng Des Sel; 2015 Jan; 28(1):9-17. PubMed ID: 25492933
[TBL] [Abstract][Full Text] [Related]
4. Control of granzymes by serpins.
Kaiserman D; Bird PI
Cell Death Differ; 2010 Apr; 17(4):586-95. PubMed ID: 19893573
[TBL] [Abstract][Full Text] [Related]
5. Overview of serpin B9 and its roles in cancer (Review).
Wang WJ; Wang J; Ouyang C; Chen C; Xu XF; Ye XQ
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278491
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for serpin inhibitor activity.
Wright HT; Scarsdale JN
Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
[TBL] [Abstract][Full Text] [Related]
7. The major human and mouse granzymes are structurally and functionally divergent.
Kaiserman D; Bird CH; Sun J; Matthews A; Ung K; Whisstock JC; Thompson PE; Trapani JA; Bird PI
J Cell Biol; 2006 Nov; 175(4):619-30. PubMed ID: 17116752
[TBL] [Abstract][Full Text] [Related]
8. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
9. Delivery and therapeutic potential of human granzyme B.
Kurschus FC; Jenne DE
Immunol Rev; 2010 May; 235(1):159-71. PubMed ID: 20536562
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of equine granzyme B.
Piuko K; Bravo IG; Müller M
Vet Immunol Immunopathol; 2007 Aug; 118(3-4):239-51. PubMed ID: 17604123
[TBL] [Abstract][Full Text] [Related]
11. Engineering an anion-binding cavity in antichymotrypsin modulates the "spring-loaded" serpin-protease interaction.
Lukacs CM; Rubin H; Christianson DW
Biochemistry; 1998 Mar; 37(10):3297-304. PubMed ID: 9521649
[TBL] [Abstract][Full Text] [Related]
12. A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.
Mangan MS; Bird CH; Kaiserman D; Matthews AY; Hitchen C; Steer DL; Thompson PE; Bird PI
J Biol Chem; 2016 Feb; 291(7):3626-38. PubMed ID: 26670609
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the nuclear localizing cytolytic granule serine protease granzyme B with importin alpha or beta: modulation by the serpin inhibitor PI-9.
Blink EJ; Jiansheng Z; Hu W; Calanni ST; Trapani JA; Bird PI; Jans DA
J Cell Biochem; 2005 Jun; 95(3):598-610. PubMed ID: 15791691
[TBL] [Abstract][Full Text] [Related]
14. The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
Bottomley SP; Lawrenson ID; Tew D; Dai W; Whisstock JC; Pike RN
Protein Sci; 2001 Dec; 10(12):2518-24. PubMed ID: 11714919
[TBL] [Abstract][Full Text] [Related]
15. Identification and activity of a lower eukaryotic serine proteinase inhibitor (serpin) from Cyanea capillata: analysis of a jellyfish serpin, jellypin.
Cole EB; Miller D; Rometo D; Greenberg RM; Brömme D; Cataltepe S; Pak SC; Mills DR; Silverman GA; Luke CJ
Biochemistry; 2004 Sep; 43(37):11750-9. PubMed ID: 15362859
[TBL] [Abstract][Full Text] [Related]
16. Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.
Scott GB; Bowles PA; Wilson EB; Meade JL; Low BC; Davison A; Blair GE; Cook GP
Biochem J; 2010 Nov; 431(3):423-31. PubMed ID: 20704564
[TBL] [Abstract][Full Text] [Related]
17. Identification of Serpinb6b as a species-specific mouse granzyme A inhibitor suggests functional divergence between human and mouse granzyme A.
Kaiserman D; Stewart SE; Plasman K; Gevaert K; Van Damme P; Bird PI
J Biol Chem; 2014 Mar; 289(13):9408-17. PubMed ID: 24505135
[TBL] [Abstract][Full Text] [Related]
18. A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.
Niesen J; Hehmann-Titt G; Woitok M; Fendel R; Barth S; Fischer R; Stein C
Cancer Lett; 2016 May; 374(2):229-40. PubMed ID: 26912070
[TBL] [Abstract][Full Text] [Related]
19. Serpin crystal structure and serpin polymer structure.
Marszal E; Shrake A
Arch Biochem Biophys; 2006 Sep; 453(1):123-9. PubMed ID: 16631102
[TBL] [Abstract][Full Text] [Related]
20. SERPINB12 Is a Slow-Binding Inhibitor of Granzyme A and Hepsin.
Niehaus JZ; Miedel MT; Good M; Wyatt AN; Pak SC; Silverman GA; Luke CJ
Biochemistry; 2015 Nov; 54(45):6756-9. PubMed ID: 26497600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
